Back to Agenda
Session 1: Keynote Address
Session Chair(s)
Jeffrey Foy, PhD
Executive Director, Toxicology, Nimbus Therapeutics, United States
Session 1: Keynote Address
Speaker(s)
Bryan Laffitte
Executive Director, Novartis, United States
Keynote Speaker
Have an account?
